Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Tamsulosin increases the risk of floppy iris during eye surgery.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Finasteride may affect fetal brain development and increase arousal, but more research is needed for safety confirmation.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Hemp-derived cannabinoids can benefit skin and hair without causing a high.

New app improves storm surge predictions; advances in baldness treatment show potential but require time.

Hair loss needs more research for better treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

More research is needed to understand sex and racial differences in long COVID.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Possible link between COVID-19 and hair loss; more research needed.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Androgens can both increase and decrease hair growth in different parts of the body.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.